v3 Template
C

Catalent, Inc.

Pharmaceutical and Biotechnology ~520 employees
Founded
--
Employees (Est.)
~520
26 leaders known
Total Funding
$600.0M
Funding Rounds
1
Last Funding
2023-12-19

About Catalent, Inc.

Catalent is a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical and biotech industries, focused on providing innovative solutions for drug development, manufacturing, and delivery to bring products to market efficiently with a 'Patient First' approach.

Products & Services

Oral Dose:Comprehensive solutions for oral drug development, including bioavailability enhancement, dose form design (tablets, capsules, softgels), and manufacturing services.
Biologics:Services for biotherapeutics, advanced therapeutics like cell and gene therapy, and related technologies.
Specialty:Specialized drug delivery solutions including inhalation (nasal delivery, dry powder inhalers), small molecule injectables, and support for orphan drugs.
Clinical Supply:Services for clinical trial supply including forecasting, packaging, comparator sourcing, and distribution logistics.
Consumer Health:Solutions for over-the-counter products, nutritional supplements, and beauty products.

Specialties

Oral Drug Delivery Bioavailability Enhancement Softgel Technologies Biologics and Cell & Gene Therapy Inhalation and Nasal Delivery Clinical Supply Services Highly Potent Active Pharmaceutical Ingredients (HPAPI) Consumer Health Products

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt 		A: 600000000
MR: -
FA: $600 million
FAN: 600000000 		D: 2023-12-19
FD: 2023-12-19 		-
Debt Latest
2023-12-19
$600.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

G

Greg Bleck, Ph.D.

Vice President of R&D, Biologics

LinkedIn (Pro only)
W

William Wei Lim Chin

GLOBAL SCIENTIFIC AFFAIRS MANAGER, SCIENCE AND TECHNOLOGY

LinkedIn (Pro only)
M

Mubashar Chughtai

Associate Senior Scientist

LinkedIn (Pro only)
C

Christin Hollis, Ph.D.

Associate Director, Product Development

D

Dejan Lamesic, Ph.D.

Head of Formulation and Process Development

D

Diogo Gomes Lopes, Ph.D.

Product Development Principal Formulation Scientist

View 23 more team members with Pro

Unlock Full Team Directory

Recent News

Catalent, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceutical and Biotechnology
Company Size
~520 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro